We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech...
EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (“XOMA” or the “Company”; Nasdaq: XOMA) entered into a merger agreement to...
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories PR Newswire CASTRES, France and SAN FRANCISCO, March 1, 2024 Kinnate has entered into...
Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets.The transaction is in furtherance...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 2.65 | 2.675 | 2.64 | 1818825 | 2.65237066 | CS |
| 12 | 0.27 | 11.3445378151 | 2.38 | 2.69 | 2.2 | 507386 | 2.56523313 | CS |
| 26 | 1.55 | 140.909090909 | 1.1 | 2.69 | 1.04 | 981967 | 2.46174766 | CS |
| 52 | 0.03 | 1.14503816794 | 2.62 | 4.5 | 1.04 | 647914 | 2.60885112 | CS |
| 156 | -24.05 | -90.074906367 | 26.7 | 27.65 | 1.04 | 308388 | 6.24571684 | CS |
| 260 | -37.35 | -93.375 | 40 | 48.75 | 1.04 | 299348 | 8.96443421 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
